The ability of niacin to influence LDL-P is under active investigation and it appears that the beneficial effects of niacin extend beyond the traditional evaluation of the 'lipid profile.' Taken ...

Patients with hyperlipidemia treated with evolocumab had a greater reduction in atherogenic lipoprotein particles compared with those who received placebo, according to a post hoc subanalysis ...

High cholesterol does not have to be a mystery or a one-size-fits-all medical prescription. For decades, statins have been ...

To determine whether dairy fat in cheese raises low-density lipoprotein (LDL) cholesterol as much as in butter, since epidemiology suggests a different impact on cardiovascular disease. A total of 14 ...

PREVAIL U.S. primary and secondary lipid endpoints and lipoprotein particle analysis presented at the National Lipid Association Scientific Sessions SCOTTSDALE, Ariz., May 31, 2012 /PRNewswire via ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In a phase 2 trial, obicetrapib, an investigational ...

The prospective data indicate that clinicians should be aggressive with lipid-lowering therapies in these patients, experts say.

Editor’s note: In this column, author Jeff Ellis describes his experience managing his cholesterol and risk for heart disease. Before embarking on any health regimen, consult with your healthcare ...

Clin Lipidology. 2009;4(5):565-571. Although the importance of LDL-P and its relation to CAD risk is still being evaluated, there appears overall to be a strong relationship between LDL-P and future ...